Navigation Links
Parker Waichman LLP Represents Wisconsin Woman in Lawsuit Alleging Mirena IUD Perforated her Uterus, Causing Serious Pain and Injuries
Date:9/17/2013

New York, New York (PRWEB) September 17, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, has filed a lawsuit alleging that the Mirena IUD perforated a Wisconsin woman’s uterus. The lawsuit was filed on Aug. 13, 2013, in the Superior Court of New Jersey Law Division, Morris County (Case No. L-6579-13). Bayer Healthcare Pharmaceuticals Inc., Bayer Healthcare Ag, Bayer Pharma Ag, and Bayer Oy were named as Defendants.

According to the Complaint, the Plaintiff was implanted with the Mirena IUD in June 2009. At that time, there was no reason to suspect that the IUD had perforated her uterus. The lawsuit points out that Bayer’s warning label only mentions the risk of spontaneous migration happening after the device is first placed in the uterus. On Jan. 31, 2011, the Plaintiff went to her doctor’s office to have an ultrasound, which revealed that the IUD may have become embedded in the wall of her uterus. An MRI confirmed the ultrasound’s findings. On Feb. 22, 2011, she underwent a laparoscopy to remove the IUD. The lawsuit is seeking compensation for severe and permanent physical injuries, substantial pain and suffering, and economic loss due to medical expenses and lost wages. The lawsuit alleges that Bayer knew that the Mirena IUD was defective but failed to warn of the risks.

The lawsuit alleges that Bayer has a history of misrepresenting Mirena. In a warning letter sent to the company by the U.S. Food and Drug Administration (FDA) on Dec. 30, 2009, the Department of Health and Human Services’ Division of Drug Marketing, Advertising, and Communications (DDMAC) criticized the company for making unsubstantiated claims about the device while failing to mention its risks in the company’s “Simple Style” program. The department also criticized the company for a number of statements, including the assertion that Mirena helps women “look and feel great.”

The lawsuit further notes that Bayer’s Mirena IUD was approved in 2000. It is a contraceptive that is supposed to prevent pregnancy for up to five years. The IUD is a small, plastic device that is attached to two strings. Once placed inside the uterus by a healthcare professional, it releases the hormone levonorgestrel.

According to an Oct. 1, 2009, FDA press release, the most serious side effects associated with the Mirena IUD include:

  •     Perforation of the uterine wall
  •     Embedment of the device in the uterine wall
  •     Intrauterine pregnancy
  •     Ectopic pregnancy
  •     Group A streptococcal sepsis
  •     Pelvic inflammatory disease (PID)

Recently, the Supreme Court of New Jersey reconsidered its previous decision and has moved to centralize Mirena IUD lawsuits in Bergen County, where Superior Court Judge Brian R. Martinotti will manage them, according to court documents.

The attorneys at Parker Waichman LLP have been actively involved in the Mirena IUD litigation. Partner Raymond C. Silverman has been appointed Co-Lead Counsel in the Mirena IUD multicounty litigation centralized in Bergen County, New Jersey. Matthew J. McCauley, Senior Litigation Counsel at Parker Waichman LLP, was previously appointed Co-Lead Counsel in the Mirena IUD multidistrict litigation in New York. Mr. McCauley also co-chairs the American Association for Justice (AAJ) Mirena IUD Litigation Group. The Group is actively involved in exchanging educational materials and medical literature in order to best represent victims.

Parker Waichman LLP continues to offer free lawsuit consultations to victims of injuries allegedly caused by the Mirena IUD. If you or a loved one experienced complications following use of this device, please visit the firm's Mirena IUD Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary P. Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636
http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/mirena_akins_mcl/09/prweb11133416.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. California Man Has Elevated Cobalt Levels and Possible Need for Revision Surgery After His Biomet Hip Implant Failed, Alleges Lawsuit Filed by Parker Waichman LLP
2. Virginia Woman Suffers Serious Injuries from Her Transvaginal Mesh Device, Alleges Parker Waichman LLP in Lawsuit
3. Transvaginal Mesh Multidistrict Litigation Update: Judge Makes Pretrial Ruling on Document Production, Reports Parker Waichman LLP
4. After Taking Diabetes Drug Actos for Nearly Seven Years, Florida Man Developed Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP
5. Judge Orders Postponement of First Bellwether Trial in DePuy Orthopaedics Inc.’s Multidistrict Litigation, Pushing It to Sept. 24, Parker Waichman LLP Reports
6. Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP
7. New York’s Attorney General Tells Consumers Not to Fall for Football Helmet Manufacturers’ Claims of Reducing the Risk of Concussion; Parker Waichman LLP Responds
8. Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
9. Florida Appeal Court Upholds $33M Judgment Against Lorillard Tobacco Co., Denying Its Request for a New Trial, Reports Parker Waichman LLP and Co-counsel
10. The FDA Issues Class 1 Recall for Stryker’s Oasys Midline Occiput Plate Due to a Key Defect, Reports Parker Waichman LLP
11. First Bellwether Trial in Multidistrict Litigation for DePuy Orthopaedics Inc.’s All-Metal Hip Implant to Commence on September 9 in Ohio’s Northern District, Reports Parker Waichman LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: